Coral Gables Symposia 2016 took place between October 5th and 7th at the Biltmore hotel in Miami Florida. The overall theme of the conference was - Immunogenicity and the patient: The Future is Yours
This year again, the event successfully provided a forum for principal actors and thought leaders in the field of immunogenicity to exchange ideas with the goal to help shape the future use of biopharmaceuticals for a more effective treatment of serious disease.
Thank you to all participants, speakers and to the scientific committee!
Scientific Programme
|
Scientific Organizing Committee 2016
Dr. Michael Tovey, Chair |
Watch out for upcoming event and news; make sure to Follow the Coral Gables Symposium LinkedIn page!
Contact
If you have any questions, please send an email to: coralgables2016@eurodiagnostica.com
______________________________________________
Mary Birchler, GSK
Dr. Ashly Buckle, Monash
Dr. Malcolm Buckle, ENS Cachan
Dr. Merry Christie, University of Colorado
Dr. Ed Clark, University of Washington
Dr. Rachael Clark, Harvard
Dr. Jorgen Dahlstrom, Thermo Fisher Scientific
Professor Florian Deisenhammer,
Dr. Shalini Gupta, Amgen, Thousand Oaks
Dr. Susan Kirshner, FDA, Bethesda
Dr. Eugen Koren
Pr. Arno Kromminga
Dr. Harald Kropshofer, Hoffman La-Roche
Professor Thomas Kupper
Dr. Bernard Maillere, CEA
Dr. Sharmila Masli, BU
Dr. Claudia Mauri, UCL
Dr. Federico Mingozzi, Children’s Hospital Philadelphia
Dr. Morten Nielsen, Technical University of Denmark
Dr. Ted Randolph, University of Colorado
Dr. Zuben Sauna, FDA Bethesda
Dr. Sebastian Spindeldreher, Novartis
Dr. Steve Swanson, Amgen
Professor Herman Waldmann, University of Oxford
Dr. Taia Wang, Rockefeller
Dr. Arie Admon, Technion – Israel Institute of Technology
Professor Antoine Blancher, University of Toulouse
Dr. Ashly Buckle, Monash
Dr. Malcolm Buckle, ENS Cachan
Dr. Jörgen Dahlstrom, Thermo Fisher Scientific, Uppsala
Professor Florian Deisenhammer, University of Innsbruck
Dr. Shalini Gupta, Amgen, Thousand Oaks
Dr. Haiyan Jiang, Biogen Idec, Cambridge
Dr. Susan Kirshner, FDA, Bethesda
Dr. Dwight Koeberl, Duke
Dr. Harald Kropshofer, Hoffman La-Roche, Basel
Professor Enrico Maggi, University di Firenze
Dr. Claudia Mauri, UCL
Dr. Federico Mingozzi, Children’s Hospital Philadelphia
Dr. Morten Nielsen, Technical University of Denmark
Dr. Ira Pastan, NIH, Bethesda
Dr. Stefan Ryser, A-Cube, Belmont CA
Dr. Jack Ragheb, FDA, Bethesda
Dr. Birgit Reipert, Baxter, Vienna
Dr. Amy Rozenberg, FDA Bethesda
Dr. Zuben Sauna, FDA Bethesda
Dr. Alessandro Sette, La Jolla institute for Allergy and Immunology
Dr. Reyna Simon, A-Cube, Belmont CA
Dr. Sebastian Spindeldreher, Novartis, Basel
Dr. Steve Swanson, Amgen, Thousand Oaks, CA
Professor Herman Waldmann, University of Oxford
Dr. Arie Admon, Technion - Israel Institute of Technology
Professor Antoine Blancher, University of Toulouse
Dr. Ashly Buckle, Monash
Dr. Malcolm Buckle, ENS Cachan
Dr. Jörgen Dahlstrom, Thermo Fisher Scientific, Uppsala
Professor Florian Deisenhammer, University of Innsbruck
Dr. Shalini Gupta, Amgen, Thousand Oaks
Dr. Haiyan Jiang, Biogen Idec, Cambridge
Dr. Susan Kirshner, FDA, Bethesda
Dr. Dwight Koeberl, Duke
Dr. Harald Kropshofer, Hoffman La-Roche, Basel
Professor Enrico Maggi, University di Firenze
Dr. Claudia Mauri, UCL
Dr. Federico Mingozzi, Children’s Hospital Philadelphia
Dr. Morten Nielsen, Technical University of Denmark
Dr Ira Pastan, NIH, Bethesda
Dr. Stefan Ryser, A-Cube, Belmont CA
Dr. Jack Ragheb, FDA, Bethesda
Dr. Birgit Reipert, Baxter, Vienna
Dr. Amy Rozenberg, FDA Bethesda
Dr. Zuben Sauna, FDA Bethesda
Dr. Alessandro Sette, La Jolla institute for Allergy and Immunology
Dr. Reyna Simon, A-Cube, Belmont CA
Dr. Sebastian Spindeldreher, Novartis, Basel
Professor Herman Waldmann, University of Oxford
